Search research articles
Contact Us
Filters
Showing results (771-780 of 817) with videos related to
Page
of 82
Sort By:
Cancer Research and Treatment
|
November 1, 2024
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study
Naoya Nishioka, Tae Hata, Tadaaki Yamada, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2024
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
Tetsuhiko Asao, Takehito Shukuya, Kohei Uemura, et al.
Cancer Science
|
January 18, 2026
Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers
Yuya Murase, Shigeki Nanjo, Sachiko Arai, et al.
Scientific Reports
|
May 6, 2026
Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study
Takaaki Masuda, Satoshi Watanabe, Ryo Suzuki, et al.
American Journal of Medical Genetics. Part A
|
January 20, 2016
Detailed analysis of 26 cases of 1q partial duplication/triplication syndrome
Satoshi Watanabe, Kenji Shimizu, Hirofumi Ohashi, et al.
Scientific Reports
|
May 16, 2019
Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study
Noriyuki Enomoto, Ryoko Egashira, Kazuhiro Tabata, et al.
Nature Communications
|
January 18, 2019
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang, et al.
Translational Lung Cancer Research
|
May 19, 2025
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan
Shiho Goda, Tadaaki Yamada, Kenji Morimoto, et al.
The Oncologist
|
November 28, 2019
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study
Kazunari Tateishi, Ryo Ko, Takehito Shukuya, et al.
Translational Lung Cancer Research
|
September 29, 2021
Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated <i>EGFR</i>-mutated advanced non-small cell lung cancer: a prospective observational study
Akihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, et al.
Page
of 82
Search research articles
Search
Showing results (771-780 of 817) with videos related to
Sort By:
Page
of 82
Cancer Research and Treatment
|
November 1, 2024
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study
Naoya Nishioka, Tae Hata, Tadaaki Yamada, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2024
Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
Tetsuhiko Asao, Takehito Shukuya, Kohei Uemura, et al.
Cancer Science
|
January 18, 2026
Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers
Yuya Murase, Shigeki Nanjo, Sachiko Arai, et al.
Scientific Reports
|
May 6, 2026
Muscle loss and pentraxin-3 as predictors of immunotherapy outcomes in non-small cell lung cancer: a prospective study
Takaaki Masuda, Satoshi Watanabe, Ryo Suzuki, et al.
American Journal of Medical Genetics. Part A
|
January 20, 2016
Detailed analysis of 26 cases of 1q partial duplication/triplication syndrome
Satoshi Watanabe, Kenji Shimizu, Hirofumi Ohashi, et al.
Scientific Reports
|
May 16, 2019
Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study
Noriyuki Enomoto, Ryoko Egashira, Kazuhiro Tabata, et al.
Nature Communications
|
January 18, 2019
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang, et al.
Translational Lung Cancer Research
|
May 19, 2025
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan
Shiho Goda, Tadaaki Yamada, Kenji Morimoto, et al.
The Oncologist
|
November 28, 2019
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study
Kazunari Tateishi, Ryo Ko, Takehito Shukuya, et al.
Translational Lung Cancer Research
|
September 29, 2021
Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated <i>EGFR</i>-mutated advanced non-small cell lung cancer: a prospective observational study
Akihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma, et al.
Page
of 82